CLNN Form 4/A: CEO Granted 40,000 Options at $5.88

Clene Inc. (CLNN) reported an amended Form 4 showing an option grant to Robert Dee Etherington, President & CEO and director.

Rhea-AI Filing Summary

Clene Inc. (CLNN) reported an amended Form 4 showing an option grant to Robert Dee Etherington, President & CEO and director. The amendment corrects the exercise price to $5.88 per share for an option covering 40,000 shares of common stock granted on 09/25/2025 under the Clene Inc. Amended 2020 Stock Plan. The options vest in 12 equal monthly installments beginning 10/25/2025 and expire on 09/24/2035. The filing was signed by Jerome T. Miraglia as POA on 09/30/2025.

Positive

• Correction filed: The amendment explicitly corrects the exercise price to $5.88, improving disclosure accuracy.
• Clear vesting schedule: The options vest in 12 equal monthly installments starting 10/25/2025, which is fully described.
• Standard option term: The option expiration date is 09/24/2035, a conventional ten‑year term.

Negative

• Original filing error: The Form 4 required an amendment because the initial filing contained an incorrect exercise price.

Insights

Corporate Governance Expert

TL;DR: Executive received a time‑based option grant of 40,000 shares at $5.88, amended to correct the exercise price.

The amendment clarifies the economic terms of the award to the CEO and confirms standard monthly vesting over 12 months, which indicates a short-term retention schedule. Correcting the exercise price improves disclosure accuracy and compliance with Section 16 filing requirements. The grant size and ten‑year term align with typical executive option practices, but the filing does not state the grant's proportion relative to outstanding shares or any performance conditions.

Compensation Analyst

TL;DR: A routine equity-based compensation action was recorded; amendment fixes an administrative error.

The award of options for 40,000 shares exercisable at $5.88 with monthly vesting over one year is a straightforward time‑based retention tool. The ten‑year expiration is conventional for stock options. The amendment solely corrects the exercise price and does not add new economic terms. There is no information here on grant-date valuation, total company dilution, or whether this replaces or supplements prior awards.

Insider Trade Summary

Grant/Award: 40,000 shares

Grant/Award 1 txn

Insider Etherington Robert Dee

Role President & CEO

Type	Security	Shares	Price	Value
Grant/Award	stock option	40,000	$0.00	$0.00

Holdings After Transaction: stock option — 40,000 contracts (Direct)

Footnotes (2)

1. F1. This Form 4 amendment is being filed to correct a Form 4 filed on September 29, 2025. The corrected exercise price is $5.88 per share.
2. F2. This option was granted on September 25, 2025 as an option for 40,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.88 per share. The options vest in 12 equal monthly installments on the 25th day of each calendar month, beginning October 25, 2025, until such shares are fully vested.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did CLNN report on this Form 4/A?

The filing reports an option grant to Robert Dee Etherington for 40,000 shares of common stock granted on 09/25/2025.

What is the corrected exercise price for the CLNN option?

The amended Form 4 states the exercise price is $5.88 per share.

When do the CLNN options vest and when do they expire?

The options vest in 12 equal monthly installments beginning 10/25/2025 and expire on 09/24/2035.

What is the reporting person’s role at CLNN?

The reporting person, Robert Dee Etherington, is listed as President & CEO and a director of Clene Inc.

Why was this Form 4 amended?

The amendment was filed to correct the exercise price reported on the Form 4 filed on 09/29/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/30/2025 - 03:56 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Etherington Robert Dee

(Last) (First) (Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY UT 84121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
09/29/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock option	$5.88(1)	09/25/2025		A		40,000		(2)	09/24/2035	common stock	40,000	$0	40,000	D

Explanation of Responses:

1. This Form 4 amendment is being filed to correct a Form 4 filed on September 29, 2025. The corrected exercise price is $5.88 per share.

2. This option was granted on September 25, 2025 as an option for 40,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.88 per share. The options vest in 12 equal monthly installments on the 25th day of each calendar month, beginning October 25, 2025, until such shares are fully vested.

	/s/ Jerome T. Miraglia POA	09/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.